Differentiation-inducing factor 1 activates cofilin through pyridoxal phosphatase and AMP-activated protein kinase, resulting in mitochondrial fission.


Journal

Journal of pharmacological sciences
ISSN: 1347-8648
Titre abrégé: J Pharmacol Sci
Pays: Japan
ID NLM: 101167001

Informations de publication

Date de publication:
May 2023
Historique:
received: 26 10 2022
revised: 09 02 2023
accepted: 14 02 2023
medline: 18 4 2023
entrez: 14 4 2023
pubmed: 15 4 2023
Statut: ppublish

Résumé

Differentiation-inducing factor 1 (DIF-1) is a morphogen produced by Dictyostelium discoideum that inhibits the proliferation and migration of both D. discoideum and most mammalian cells. Herein, we assessed the effect of DIF-1 on mitochondria, because DIF-3, which is similar to DIF-1, reportedly localizes in the mitochondria when added exogenously, however the significance of this localization remains unclear. Cofilin is an actin depolymerization factor that is activated by dephosphorylation at Ser-3. By regulating the actin cytoskeleton, cofilin induces mitochondrial fission, the first step in mitophagy. Here, we report that DIF-1 activates cofilin and induces mitochondrial fission and mitophagy mainly using human umbilical vein endothelial cells (HUVECs). AMP-activated kinase (AMPK), a downstream molecule of DIF-1 signaling, is required for cofilin activation. Pyridoxal phosphatase (PDXP)-known to directly dephosphorylate cofilin-is also required for the effect of DIF-1 on cofilin, indicating that DIF-1 activates cofilin through AMPK and PDXP. Cofilin knockdown inhibits mitochondrial fission and decreases mitofusin 2 (Mfn2) protein levels, a hallmark of mitophagy. Taken together, these results indicate that cofilin is required for DIF-1- induced mitochondrial fission and mitophagy.

Identifiants

pubmed: 37059490
pii: S1347-8613(23)00011-7
doi: 10.1016/j.jphs.2023.02.009
pii:
doi:

Substances chimiques

AMP-Activated Protein Kinases EC 2.7.11.31
Actin Depolymerizing Factors 0
Phosphoric Monoester Hydrolases EC 3.1.3.2
Pyridoxal 3THM379K8A
Hexanones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-49

Informations de copyright

Copyright © 2023 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors indicated no potential conflict of interest.

Auteurs

Takeru Inoue (T)

Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, 812-8582 Fukuoka, Japan.

Koichi Miura (K)

Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, 812-8582 Fukuoka, Japan. Electronic address: miura.koichi.468@m.kyushu-u.ac.jp.

Ruzhe Han (R)

Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, 812-8582 Fukuoka, Japan.

Fumi Seto-Tetsuo (F)

Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, 812-8582 Fukuoka, Japan; Department of Microbiology and Oral Infection, Infection Research, Graduate School of Biochemical Sciences, Nagasaki University, Nagasaki, 852-8588, Japan.

Masaki Arioka (M)

Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, 812-8582 Fukuoka, Japan; Department of Pharmacology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Fukuoka, 807-8555, Japan.

Kazunobu Igawa (K)

Institute for Materials Chemistry and Engineering, Kyushu University, Kasuga, Japan.

Katsuhiko Tomooka (K)

Institute for Materials Chemistry and Engineering, Kyushu University, Kasuga, Japan.

Toshiyuki Sasaguri (T)

Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, 812-8582 Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH